Septic Shock Market
Number of pages: 100 | Report Format: PDF | Published date: March 01, 2023
Historical Years – 2020 | Base Year – 2021 | Forecasted Years – 2022-2030
|
Report Attribute |
Details |
|
Market Size Value in 2021 |
US$ 3.5 billion |
|
Revenue Forecast in 2030 |
US$ 6.54 billion |
|
CAGR |
7.2% |
|
Base Year for Estimation |
2021 |
|
Forecast Period |
2022-2030 |
|
Historical Year |
2020 |
|
Segments Covered |
Therapy Type, End User, and Region |
|
Regional Scope |
North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa |
According to the deep-dive market assessment study by Growth Plus Reports, the global septic shock market was valued at US$ 3.5 billion in 2021 and is expected to register a revenue CAGR of 7.2% to reach US$ 6.54 billion by 2030.
Septic Shock Market Fundamentals
Septic shock occurs whenever an infection spreads throughout the body and causes dangerously low blood pressure. A subgroup of sepsis patients experiences septic shock, characterized by an underlying metabolic, circulatory, and cellular imbalance linked to a higher fatality rate. Some signs of septic shock include a blood lactate level over 2 mmol/L (18 mg/dL) and persistent hypotension requiring vasopressors to maintain a mean arterial pressure of 65 mm Hg or higher. Sepsis can swiftly progress from the initial stages to the more severe forms, including septic shock, and once this happens, the death may rise. There may be an overlap between the signs of severe sepsis and septic shock, which might include abrupt confusion, dizziness, severe breathing issues, and bluish staining of the lips or digits (cyanosis).
People going through septic shock also have irregular blood flow that can cause organ malfunction, extremely low blood pressure that does not react to fluid replacement, and other symptoms. Septic shock is more likely to occur in newborns, young children, elderly people, pregnant women, and people with chronic illnesses. Chronic conditions, such as diabetes, cirrhosis, cancer, AIDS/HIV, renal, and heart disease, raise the risk of septic shock. Pathogenesis is characterized by a complicated cellular activation response that releases a wide range of proinflammatory mediators. Leukocytes, endothelial cells, and a coagulation system are all activated as a result of this inflammatory response. Tumor necrosis factor-alpha (TNF-) and interleukin-1 (IL-1) cytokines are crucial to the pathophysiology of septic shock and work together to cause hypotension in experimental models. High-mobility group box 1 (HMGB1) protein is another important mediator that plays a significant role.
Studies have shown that even small delays in treating severe sepsis and septic shock can raise the chance of death as it is a serious condition. Antibiotics are among the medications used to treat sepsis and septic shock; they should be started as soon as a diagnosis is completed and injected straight into a vein. Vasopressors are required to maintain appropriate blood pressure in patients with septic shock. Anti-inflammatory medications, such as corticosteroids, are prescribed to patients whose blood pressure and heart rate remain unstable despite receiving fluids and vasopressors. According to reviews, corticosteroids can be more beneficial for people with more severe septic shock cases. Other drugs include insulin to maintain blood sugar levels and stop the patient from developing hyperglycemia. Dehydration can be treated with large doses of intravenous fluids, which can also help raise blood pressure and improve blood flow to the organs. For breathing, a respirator might also be required. A source of infection may be surgically removed, such as by draining an abscess filled with pus or removing contaminated tissue.
[68577775]
Septic Shock Market Dynamics
The global septic shock market is a rapidly growing sector in the healthcare industry. This can be attributed to the increasing prevalence of septic shock cases, due to a combination of the aging population and the emergence of antibiotic-resistant bacteria, which has led to an increased demand for treatment options. Also, the global septic shock market has grown exponentially in recent years, offering patients and providers a variety of medical options. In addition, research into developing new treatments for septic shock is ongoing, with many promising new therapies and treatments currently in development. As the septic shock market continues to grow, the number of treatments and services available for patients is expected to continue to increase.
Lack of information regarding sepsis, characterized by persistent local and systemic infection and resulting in organ failure, is a major factor impeding the revenue growth of the global septic shock market. A further factor impeding the growth of the global septic shock market is the high cost of existing treatments.
Septic Shock Market Ecosystem
The global septic shock market has been analyzed from three perspectives: therapy type, end user, and region.
Septic Shock Market by Therapy Type
[435355345]
Based on therapy type, the global septic shock market has been segmented into anti-infectives, vasopressors, corticosteroids, and others.
The anti-infectives segment accounts for the largest global septic shock market revenue share. Septic shock is a life-threatening condition that occurs when an infection causes a dramatic drop in blood pressure. It is a medical emergency requiring immediate treatment with anti-infectives. Other treatments include vasopressors and corticosteroids, depending on the patient’s condition. It is important to seek medical attention immediately to prevent further complications from septic shock. These drugs are used as soon as the infection subsides. Thus, both segments account for a small share of the global septic shock market. Other therapies include oxygen and fluid replacement.
Septic Shock Market by End User
Based on end user, the global septic shock market has been segmented into hospitals, ambulatory surgical centers, and specialty clinics.
The hospitals segment accounts for the largest global septic shock market revenue share. Hospitals are facing a growing number of septic shock cases as healthcare providers are increasingly aware of the dangers sepsis poses to both patients and medical staff. As a result, hospitals have implemented more stringent protocols and processes to prevent, diagnose, and treat septic shock. These protocols involve screening patients for risk factors, closely monitoring vital signs, and providing prompt and effective treatment. In addition, hospitals have increased their resources for treating sepsis, including additional personnel and better-equipped intensive care units. These efforts aim to reduce the number of septic shock cases and improve the outcome in sepsis patients.
Septic Shock Market by Region
Based on the region, the global septic shock market has been segmented into North America, Europe, Asia Pacific, and the Rest of the World.
North America accounted for the largest global septic shock market revenue share. Septic shock is a life-threatening medical condition affecting over 1.7 million people in North America annually. It results from a bacterial infection in the bloodstream. Several factors, including poor hygiene, inadequate medical care, and a weakened immune system, can cause a septic shock. Due to the seriousness of the condition, the North America market for septic shock is highly competitive. Pharmaceutical companies and healthcare providers compete to provide the most effective and efficient treatments for septic shock, often involving antibiotics and other medications. In addition, ongoing medical research and development projects to find new and improved treatments for septic shock are expected to fuel development in the regional market in the upcoming years.
Septic Shock Market Competitive Landscape
The prominent players operating in the global septic shock market are:
Septic Shock Market Strategic Developments
The global septic shock market is expected to grow at a revenue CAGR of 7.2% during the forecast period from 2022 to 2030.
F. Hoffman La-Roche Ltd., Pfizer Inc., Novartis AG, Abbott Laboratories, and Baxter International are among the key players in the global market.
The anti-infectives segment dominates the global septic shock market.
Asia Pacific is expected to register the highest revenue growth in the global septic shock market during the forecast period.
The global septic shock market was valued at US$ 3.5 billion in 2021.
*Insights on financial performance are subject to the availability of information in the public domain